Join P95 Julius Clinical at World Vaccine Congress 2026 in Amsterdam from October 19-21, 2026

Stop by booth #310 to meet our clinical and real-world evidence experts to discover how we support vaccine and infectious disease development from early clinical trials through real-world evidence generation. Our team partners with biotech and pharmaceutical companies to deliver high-quality research and evidence generation that supports informed decision-making throughout the product lifecycle.

Advancing vaccine development through science-led research

P95 Julius Clinical supports vaccine developers through every stage of evidence generation, from clinical development to post-authorization and real-world evidence studies. Our scientific and operational experts help sponsors address complex research questions with confidence.

Explore our solutions

Why P95 Julius Clinical?

• Deep expertise in vaccines and infectious diseases
• Global clinical research capabilities
• Epidemiology and disease burden studies
• Real-world evidence generation
• Flexible, science-led partnership approach